Rizwan Suliankatchi Abdulkader

Cardiac MRI-guided therapeutics in ischemic cardiomyopathy: impact on heart-team consensus and outcomes

Deepak Reddy Karumuri, Jebaraj Rathinasamy, Anant Akash Sakthivel, Harikaran Reddy Ragireddy et autres

Aims Our study aims to evaluate the influence of myocardial viability on therapeutic decision-making using cardiac MRI (CMR) and assess agreement and variability in heart-team therapeutic recommendations across different heart teams. Methodology We included patients who underwent coronary angiography and CMR between …

in, ca, gb (code pays fourni par la source)

Immunotherapeutic effect of MIP vaccine along with multidrug therapy (MDT) in leprosy: A systematic review and meta-analysis

Madhumathi Jayaprakasam, Jigisha Chaudhary, Deenadayalan Boopalan, Rizwan Suliankatchi Abdulkader et autres

Background and objectives Leprosy is a neglected tropical disease caused by Mycobacterium leprae often resulting in nerve damage, numbness, disfiguring lesions, and disability. India accounts for ∼52% of the world's new leprosy patients. Immunotherapy has been reported to achieve faster bacterial clearance …

in (code pays fourni par la source)

Global and regional progress towards reduced burden of oral conditions between 2019 and 2023: a systematic analysis for the Global Burden of Disease Study 2023

Eduardo Bernabé, Marcenes Wagner, Abdullah, Hazim S Ababneh et autres

BACKGROUND: WHO's Global Oral Health Action Plan (GOHAP) targets include a 10% relative reduction in the combined prevalence of main oral conditions by 2030. The first GOHAP evaluation was planned for 2023, with subsequent evaluations scheduled for 2026 and 2030. The aim …

Evaluation of an “upfront molecular testing” strategy under the National Tuberculosis Elimination Programme (NTEP) in Thiruvananthapuram, Kerala, India

Aby Robinson, Abey Sushan, Hari Kumar, Rakesh P S et autres

Background India's National Tuberculosis Elimination Programme (NTEP) aims to eliminate Tuberculosis (TB) by 2025. Shifting from sputum smear microscopy to more sensitive nucleic acid amplification tests (NAATs) for TB diagnosis is an important step in that direction. This study aimed to describe …

in, us (code pays fourni par la source)

Global, regional, and national burden of HIV/AIDS, 1990–2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023

Austin Carter, Meixin Zhang, Bricia Trejo, Megan Verma et autres

COMPARATIVE EFFICACY OF HIGH-INTENSITY STATIN MONOTHERAPY VS ROSUVASTATIN, BEMPEDOIC ACID, AND EZETIMIBE TRIPLE THERAPY FOR SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME: ROBE-ACS RANDOMIZED CONTROLLED TRIAL

Nagendra Boopathy Senguttuvan, Dharaneswari Hari Narayanan, Swetharajan Gunasekar, Hemalatha Ramakrishnan et autres

Long‐Term Cardiovascular Outcomes Following Percutaneous Coronary Intervention of Diffuse Coronary Artery Lesions With Overlapping Homogeneous Versus Heterogeneous Second‐Generation Drug‐Eluting Stents

Nagendra Boopathy Senguttuvan, Salman Salahuddin, Rizwan Suliankatchi Abdulkader, Swetharajan Gunasekar et autres

BACKGROUND AND AIMS: The growing prevalence and severity of diffuse coronary artery disease (dCAD) necessitate the utilization of appropriate stenting techniques to ensure complete target lesion coverage. In clinical settings where overlapping stents are the norm, there is inconclusive evidence to determine …

in, us (code pays fourni par la source)

Supplementary Appendix 1: GBD 2023 Meningitis & Antimicrobial Resistance Collaborators. Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurol 2026; published online March 27. https://doi.org/10.1016/ S1474-4422(26)00101-8.

Sarah Brooke Sirota, Rose Bender, Regina-Mae Villanueva Dominguez, Avina Vongpradith et autres

Stillbirths at 22- and 28-weeks’ gestation or longer for the states in India: findings from the Global Burden of Disease Study 2023

Rakhi Dandona, G Anil Kumar, Haley Comfort, Theresa A. McHugh et autres

Background: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), for the first time, estimated stillbirth rate (SBR) by the WHO ICD-11 definition (≥22 weeks' gestation) for 204 countries, highlighting the extent of underestimation in stillbirth burden as compared with …

Mapping drivers of life expectancy change in Asia from 1990 to 2023

GBD 2023 Asia Life Expectancy Collaborators, Jiseung Kang, Hyeon Jin Kim, Min Seo Kim et autres

Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Avina Vongpradith, Regina-Mae Villanueva Dominguez, Lorainne Tudor Car, Amanda Movo et autres

us, gb, in, jo, Éthiopie, ir, Égypte, sa, iq, ye, pk, Nigéria, my, kz, Ghana, au, de, kh, ae, qa, np, Afrique du Sud, ca, id, nz (code pays fourni par la source)

Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study

GBD 2023 IHD & Dietary Risk Factors Collaborators, Sooji Lee, Hayeon Lee, Yejun Son et autres

kr, jo, it, ir, Égypte, ca, Éthiopie, Algérie, in, Nigéria, Ghana, au, us, br, jp, ae, qa, sa, np, id, pk, nz, lb, Soudan, Rwanda, cn, om, bh, iq, ye, be, hk, ps, my, gb, Ouganda, co (code pays fourni par la source)